Keros Therapeutics, Inc. (KROS)
11.67
-0.11
(-0.93%)
USD |
NASDAQ |
May 07, 10:28
Keros Therapeutics Free Cash Flow : 105.95M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics, Inc. | -332.39M |
| PTC Therapeutics, Inc. | 411.18M |
| Insmed, Inc. | -997.58M |
| United Therapeutics Corp. | 1.011B |
| Opus Genetics, Inc. | -35.25M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.29M |
| Cash from Investing (Quarterly) | -0.134M |
| Cash from Financing (Quarterly) | -378.63M |
| Free Cash Flow Per Share (Quarterly) | -1.008 |
| Free Cash Flow to Equity (Quarterly) | -26.88M |
| Free Cash Flow to Firm (Quarterly) | -27.43M |
| Free Cash Flow Yield | 24.30% |